NYSNA Blog

Subscribe to the NYSNA Blog RSS

The purpose of this advisory is to call your attention to important guidelines for the safe use of insulin pens. Recently, two facilities in New York State discovered that insulin pens, designed for use on a single patient, had been used or might have been used for multiple patients.

Read more >>

The anemia drug peginesatide (Omontys, Affymax and Takeda Pharmaceuticals) has been voluntarily recalled by the manufacturers, after reports of anaphylaxis leading to 3 deaths, the US Food and Drug Administration (FDA) announced today.
 

Read more >>

Pages

Connect With Us

Sign Up For Email Updates

Optional Member Code

Sign Up For Text Alerts

Optional Member Code